Axogen (AXGN) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.96% |
| Dec 31, 2025 | 1.94% |
| Sep 30, 2025 | 2.22% |
| Mar 31, 2025 | 6.25% |
| Dec 31, 2024 | 5.67% |
| Sep 30, 2024 | 4.48% |
| Jun 30, 2024 | 3.82% |
| Mar 31, 2024 | 3.05% |
| Dec 31, 2023 | 4.21% |
| Sep 30, 2023 | 3.78% |
| Jun 30, 2023 | 3.60% |
| Mar 31, 2023 | 27.99% |
| Dec 31, 2022 | 27.11% |
| Sep 30, 2022 | 35.87% |
| Jun 30, 2022 | 35.60% |
| Mar 31, 2022 | 35.55% |
| Dec 31, 2021 | 35.02% |
| Sep 30, 2021 | 46.82% |
| Jun 30, 2021 | 45.99% |
| Mar 31, 2021 | 42.58% |
| Dec 31, 2020 | 40.56% |
| Sep 30, 2020 | 36.51% |
| Mar 31, 2020 | 38.79% |
| Dec 31, 2019 | 56.64% |
| Sep 30, 2019 | 50.31% |
| Jun 30, 2019 | 47.54% |
| Mar 31, 2019 | 45.55% |
| Dec 31, 2018 | 42.06% |
| Sep 30, 2018 | 40.28% |
| Jun 30, 2018 | 59.25% |
| Mar 31, 2018 | 25.32% |
| Dec 31, 2017 | 23.82% |
| Sep 30, 2017 | 34.22% |
| Jun 30, 2017 | 34.17% |
| Mar 31, 2017 | 32.80% |
| Dec 31, 2016 | 29.98% |
| Sep 30, 2016 | 16.34% |
| Jun 30, 2016 | 21.16% |
| Dec 31, 2015 | 41.78% |